Analysis of the rs20541 (R130Q) polymorphism in the IL-13 gene in patients with elderly-associated chronic inflammatory diseases;Análisis del polimorfismo rs20541 (R130Q) del gen de la IL-13 en pacientes con enfermedades inflamatorias crónicas asociadas al envejecimiento

Reumatologia Clinica

Volumn 8, Issue 6, 2012, Pages 321-327

  Álvarez Rodríguez, Lorena ^a   López Hoyos, Marcos ^a   Carrasco Marín, Eugenio ^a   Mata, Cristina ^b   Calvo Alén, Jaime ^b   Aurrecoechea, Elena ^b   Blanco, Ricardo ^a   Ruiz, Teresa ^b   Muñoz Cacho, Pedro ^c   Villa, Ignacio ^b   Martínez Taboada, Víctor Manuel ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL SIERRALLANA   (Spain)

^c Servicio Cantabro de Salud Polanco   (Spain)

Author keywords

Aging; Elderly onset rheumatoid arthritis; Giant cell arteritis; Interleukin 13; Polymophism; Polymyalgia rheumatica

Indexed keywords

INTERLEUKIN 13;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ELDERLY ASSOCIATED CHRONIC INFLAMMATORY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GIANT CELL ARTERITIS; HETEROZYGOTE; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; ONSET AGE; POLYMERASE CHAIN REACTION; PREDICTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; GENOTYPE; GENOTYPING TECHNIQUES; GIANT CELL ARTERITIS; HUMANS; INTERLEUKIN-13; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMYALGIA RHEUMATICA;

EID: 84868629270     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2012.04.006     Document Type: Article

References (33)

1. Pawelec G., Solana R. Immunosenescence. Immunol Today 1997, 18:514-516.
2. Castle S.C. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000, 31:578-585.
3. Martínez-Taboada V.M., Goronzy J.J., Weyand C.M. Conceptos actuales sobre la patogenia de la arteritis de células gigantes. Rev Esp Reumatol 1994, 2:293-299.
4. Armona J, Rodríguez Valverde V, González-Gay MA, Figueroa M, Fernández-Suerio JL, Blanco R, et al. Arteritis de células gigantes, Estudio de 191 pacientes. Med Clin (Barc) 1995;105:734-7.
5. Huston K.A., Hunder G.G., Lie J.T., Kennedy K.H., Elveback L.R. Temporal arteritis. A 25 year epidemiological, clinical and pathologic study. Ann Intern Med 1978, 88:162-167.
6. González-Gay M.A., Blanco R., Rodríguez-Valverde V., Martínez-Taboada V.M., Delgado-Rodriguez M., Figueroa M., et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis, Predictors and response to treatment. Arthritis Rheum 1998, 41:1497-1504.
7. Brack A., Martínez-Taboada V.M., Stanson A., Goronzy J.J., Weyand C.M. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999, 42:311-317.
8. Chuang T.Y., Hunder G.G., Ilstrup D.M., Kurland L.T. Polymyalgia rheumatica: a 10- year epidemiologic and clinical study. Ann Intern Med 1982, 97:672-680.
9. Fito C., Martínez-Taboada V.M., Blanco R., Sánchez-Andrada S., Rodríguez-Valverde V., Figueroa M., et al. Long-term outcome of 162 patients with polymyalgia rheumatica. Arthritis Rheum 1998, 41(suppl. 9):S356.
10. Hunder G.G., Goronzy J.J., Weyand C.M. Is seronegative RA in the elderly the same as polymyalgia rheumatica. Bull Rheum Dis 1994, 43:1-3.
11. Weyand C.M., Goronzy J.J. Giant cell arteritis as an antigen driven disease. Rheum Dis Clin North Am 1995, 21:1027-1039.
12. Martínez-Taboada V.M., Alvarez-Rodriguez L., Ruiz Soto M., Marin M.J., López-Hoyos M. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine 2008, 44:207-220.
13. Amoli M.M., González-Gay M.A., Zeggini E., Salway F., Garcia-Porrua C., Ollier W.E.R. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis. J Rheumatol 2004, 31:2413-2417.
14. Chomarat P., Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998, 17:1-52.
15. Briere F., Bridon J.M., Servet C., Rousset F., Zurawski G., Banchereau J. IL-10 and IL-13 as B cell growth and differentiation factors. Nouv Rev Fr, Hematol 1993, 35:233-235.
16. Punnonen J., Aversa G., Cocks B.G., McKenzie A.N., Menon S., Zurawski G., et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993, 90:3730-3734.
17. Vercelli D. Genetics of IL-13 and functional relevance of IL-13 variants. Curr Opin Allergy Clin Immunol 2002, 2:389-393.
18. Graves P.E., Kabesch M., Halonen M., Holberg C.J., Baldini M., Fritzsch C., et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000, 105:506-513.
19. Heinzmann A., Mao X.Q., Akaiwa M., Kreomer R.T., Gao P.S., Ohshima K., et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000, 9:549-559.
20. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990 criteria for the Classification of giant cell arteritis. Arthrirtis Rheum 1990, 33:1122-1128.
21. Martínez-Taboada V., Brack A., Hunder G.G., Goronzy J.J., Weyand C.M. The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol 1996, 23:1011-1014.
22. González-Gay M.A., Rodríguez-Valverde V., Blanco R., Fernández-Sueiro J.L., Armona J., Figueroa M., et al. Polymyalgia rheumatica without significantly increased ESR: A more benign syndrome. Arch Intern Med 1997, 157:317-320.
23. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
24. Hellier J.P., Eliaou J.F., Daures J.P., Sany J., Combe B. HLA-DRB1 genes and patients with late onset rheumatoid arthritis. Ann Rheum Dis 2001, 60:531-533.
25. Martínez-Taboada V., Blanco R., Rodriguez-Valverde V. Arteritis de células gigantes. Semin Fund Esp Reumatol 2000, 1:141-157.
26. Granel B., Chevillard C., Allanore Y., Arnaud V., Cabantous S., Marquet S., et al. Evaluation of interleukin 13 polymorphisms in systemic sclerosis. Immunogenetics 2006, 58:693-699.
27. Duffin K.C., Freeny I.C., Schrodi S.J., Wong B., Feng B.J., Soltani-Arabshahi R., et al. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol 2009, 129:2777-2783.
28. Bowes J., Eyre S., Flynn E., Ho P., Salah S., Warren R.B., et al. Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Ann Rheum Dis 2011, 70:1016-1019.
29. Bottema R.W., Nolte I.M., Howard T.D., Koppelman G.H., Dubois A.E., De Meer G., et al. Interleukin 13 and interleukin 4 receptor-α polymorphisms in rhinitis and asthma. Int Arch Allergy Immunol 2010, 153:259-267.
30. Arima K., Umeshita-Suyama R., Sakata Y., Akaiwa M., Mao X.Q., Enomoto T., et al. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol 2002, 109:980-987.
31. Vladich F.D., Brazille S.M., Stern D., Peck M.L., Ghittoni R., Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 2005, 115:747-754.
32. Spadaro A., Rinaldi T., Riccieri V., Valesini G., Taccari E. Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis. Ann Rheum Dis 2002, 61:174-176.
33. Spadaro A., Rinaldi T., Riccieri V., Taccari E., Valesini G. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile. Clin Exp Rheumatol 2002, 20:213-216.